China Oncology Focus Limited Receives Approval by Chinese Authorities to Begin Clinical Trials in Three Separate Cancer Indications Using Sorrento’s Anti-PD-L1 Monoclonal Antibody Jan 29, 2018 Life Science
Prairie Provident Announces 2017 Year-End Reserves and 2018 Budget and Posts Updated Presentation Jan 29, 2018 Life Science
Lexaria Enters Licensing Agreement with Canadian Cannabis Chocolate Manufacturer Jan 25, 2018 Technology